Cross, M., Bach, E., Tran, T., Krahl, R., Jaekel, N., Niederwieser, D., . . . Al-Ali, H. K. (2013). Pretreatment long interspersed element (LINE)-1 methylation levels, not early hypomethylation under treatment, predict hematological response to azacitidine in elderly patients with acute myeloid leukemia. Dove Medical Press.
Citação norma ChicagoCross, Michael, Enrica Bach, Thao Tran, Rainer Krahl, Nadja Jaekel, Dietger Niederwieser, Christian Junghanss, Georg Maschmeyer, and Haifa Kathrin Al-Ali. Pretreatment Long Interspersed Element (LINE)-1 Methylation Levels, Not Early Hypomethylation Under Treatment, Predict Hematological Response to Azacitidine in Elderly Patients With Acute Myeloid Leukemia. Dove Medical Press, 2013.
Citação norma MLACross, Michael, et al. Pretreatment Long Interspersed Element (LINE)-1 Methylation Levels, Not Early Hypomethylation Under Treatment, Predict Hematological Response to Azacitidine in Elderly Patients With Acute Myeloid Leukemia. Dove Medical Press, 2013.